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Abstract
Atrazine (ATR) remains a widely used broadleaf herbicide in the United States despite the fact that this s-chlorotriazine has
been linked to reproductive abnormalities in fish and amphibians. Here, using zebrafish we report that environmentally
relevant ATR concentrations elevated zcyp19a1 expression encoding aromatase (2.2 mg/L), and increased the ratio of female
to male fish (22 mg/L). ATR selectively increased zcyp19a1, a known gene target of the nuclear receptor SF-1 (NR5A1),
whereas zcyp19a2, which is estrogen responsive, remained unchanged. Remarkably, in mammalian cells ATR functions in a
cell-specific manner to upregulate SF-1 targets and other genes critical for steroid synthesis and reproduction, including
Cyp19A1, StAR, Cyp11A1, hCG, FSTL3, LHß, INHa, aGSU, and 11ß-HSD2. Our data appear to eliminate the possibility that ATR
directly affects SF-1 DNA- or ligand-binding. Instead, we suggest that the stimulatory effects of ATR on the NR5A receptor
subfamily (SF-1, LRH-1, and zff1d) are likely mediated by receptor phosphorylation, amplification of cAMP and PI3K
signaling, and possibly an increase in the cAMP-responsive cellular kinase SGK-1, which is known to be upregulated in
infertile women. Taken together, we propose that this pervasive and persistent environmental chemical alters hormone
networks via convergence of NR5A activity and cAMP signaling, to potentially disrupt normal endocrine development and
function in lower and higher vertebrates.
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Introduction
Endocrine disrupting chemicals (EDCs) affect the reproductive
health of fish and amphibious wild life [1], but their impact on
mammals and particularly humans is less clear. Synthetic and
natural endocrine disruptors fall into several chemical categories
and include industrial chemicals, pesticides and herbicides. Some
of these EDCs, such as the active chemical found in polycarbonate
containers, bisphenol A, exhibit estrogenic effects in cultured cells
[2,3,4,5], by binding directly to the estrogen receptors ERa and
ERb [6,7,8]. However, other EDCs fail to competitively bind ERs,
including the widely used chlorotriazine herbicide atrazine (ATR)
[8,9].
The prevalent use of ATR as a broadleaf herbicide and its
persistence in the environment underscores the importance of
understanding the molecular impact of this EDC. Numerous
studies in fish, amphibians, reptiles and mammals all suggest that
ATR can alter normal endocrine, neuroendocrine and immune
responses. For instance, in amphibians, low levels (0.1–25 mg/L)
or short term exposure (48 hrs) to ATR, respectively, increases the
number of intersex frogs [10,11,12,13], and impairs normal
gonadal development [14,15]. Consistent with these phenotypes,
acute exposure to ATR lowers testosterone levels and impairs
gonadal development in young fish [16,17], in the developing
alligator [18], and in young peripubertal male rats [19]. However,
other studies suggest that reduced serum testosterone after ATR
exposure results from a marked drop in body weight and food
consumption. These latter effects are observed for both male and
females rats and potentially reflect an unknown role of ATR in
neuroendocrine signaling [20,21,22]. Still others suggest that
independent of body weight and hormone levels, ATR delays
mammary gland development [23]. Although there is ample
literature documenting the effects of ATR in a variety of species,
with the exception of aromatase (Cyp19A), other molecular targets
of ATR remain poorly defined.
Maintenance of cytochrome p450 aromatase activity, which
catalyzes the conversion of androgens to estrogens appears critical
for preserving a balanced sex ratio in teleosts. All species lacking
sex chromosomes, such as fish [24], are especially sensitive to
environmental factors that perturb sex steroid levels. Indeed,
increasing estrogen levels in a natural or laboratory setting
feminized [25], and greatly altered normal sex ratios in fish [26].
Conversely, treatment with aromatase inhibitors results in gonadal
masculinization of female fish [27,28]. This fact positions
aromatase as a potentially useful target to examine the in vivo
effects of ATR. In mammals, both ERa and the NR5A nuclear
receptor, steroidogenic factor 1 (SF-1) influence expression of the
single Cyp19A gene encoding aromatase. In zebrafish (Danio rerio),
regulating aromatase expression is more complex because of gene
duplication. The gonadal-enriched zcyp19a1 contains an NR5A
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LRH-1 orthologs (ff1a, b, c and d) [24], whereas the brain-
enriched zcyp19a2 contains an estrogen response element (ERE)
and is responsive to estrogens [29,30] (Fig 1). Both zebrafish
aromatase promoters contain CREB binding sites and would
therefore be responsive to cAMP signaling. Not surprisingly,
studies using several fish species showed upregulation of zcyp19a2,
with a notable downregulation of zcyp19a1 after exposure to
estrogen, xenoestrogens and other estrogenic chemicals [31,32].
While a direct link between ATR and zcyp19a1 has not be
established, others have shown that at relatively low doses (0.1 mM
or 22 mg/L) ATR greatly increases aromatase activity in selective
mammalian cell lines [33] and in immortalized sea turtle cells [34].
Recently, ATR has been proposed to bind and activate SF-1
[35]. This notion is particularly appealing given that SF-1
orthologs are found in all vertebrates including teleosts, and given
the critical role of SF-1 in mammalian sexual development and
steroidogenesis [36,37]. Here, we used mammalian cell lines and
zebrafish as model systems to address the in vivo and in vitro roles
of ATR in activating aromatase expression. We specifically asked
whether Cyp19A1, a known target of the NR5A receptors (SF-1,
LRH-1, ff1d), would be selectively activated by ATR using these
Figure 1. ATR stimulates expression of gonadal zcyp19A1 encoding aromatase, but not zcypA2 in zebrafish. Schematic of zCyp19a1 and
zCyp19a2 zebrafish promoters with binding sites and start site indicated (arrow) as previously shown by [29]. A. Relative expression of zCyp19a1 and
zCyp19a2 transcripts determined by RT-qPCR in juvenile zebrafish(20 dpf) following exposure (72 hrs) to endocrinedisruptors including 0.1 mMo f1 7 bE2,
1 mM of genistein (Gen), 10 mM of 4-nonylphenol (4-NP), 10 mM of bisphenol A (Bis A) and 10 mM of atrazine (ATR) beginning at 17dpf. B. Relative
expression of zCyp19a1 and zCypA2 transcripts in dissected 20 dpf zebrafish bodies and heads after 72 hrs ATR treatment (10 mM). C. Relative zCyp19a1
and zCyp19a2 transcript levels are shown with ATR stimulation at doses ranging from 0.01 to 10 mM for 72 hrs (left panel), or at different time points (hrs)
with 10 mM ATR (right panel). For all panels error bars represent the S.E.M. obtained from analysis of three independent groups of fish (n=5) using
validated primers, with reactions carried out three times each. T-test analysis reveal statistical significance with **p,0.01, *p,0.05.
doi:10.1371/journal.pone.0002117.g001
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hypothesize that all NR5A receptors and tissues expressing these
receptors are especially sensitive to the effects of ATR. Additionally,
we propose that at environmentally relevant concentrations this
herbicide does indeed act as an endocrine disruptor in fish, and
based on our cellular data has the potential to influence the
developing and adult endocrine system in mammals.
Results
ATR upregulates zcyp19a1 and alters the sex-ratio in
zebrafish
To determine whether ATR and other endocrine disruptors
might affect NR5A receptor activity in vivo, sexually immature
zebrafish larvae were exposed to different chemicals for their
potential to regulate zcyp19a1. Using quantitative PCR (qPCR) we
found robust increases in expression of zcyp19a1, but not zcyp19a2
after acute exposureto ATR(1 mM)in17 days postfertilization (dpf)
zebrafish (Fig 1A). As shown previously [31], estradiol (E2), the
phyto-estrogen, genistein, and the industrial chemical bisphenol A,
all elevated the relative expression of zcyp19a2 after 3 days of
exposure consistent with an ERE present in the proximal promoter
(Fig.1A).The induction of zcyp19a2 by estrogens (E2, genistein) isin
stark contrast to their significant down regulation of zcyp19a1
(Fig 1A, left panel). Further analysis of these two aromatase
transcripts in the zebrafish head and body confirmed that ATR
exposure only affected zcyp19a1, but had no effect on expression of
the brain-enriched zcyp19a2 (Fig 1B). Regulation of zcyp19a1 by
ATR was dose and time dependent with maximal effects detected at
48 hrs, and with 10 mM of drug added (Fig 1C, D). Statistically
significant responses were observed at lower doses of 0.01 and
0.1 mM ATR, which equate to 2.2 to 22 ppb (mg/L), respectively.
Reported ATR concentrations in impacted agricultural areas are
reported to be 6 to 20 ppb [11], illustrating that significant increases
in endogenous aromatase expression are observed at ecologically
relevant levels of this compound.
Given that ATR increased endogenous levels of gonadal
zcyp19a1 after short exposures, we asked if the ratio of male to
female fish would be influenced by chronic exposure (six months)
to this herbicide. Indeed, a dose-dependent increase in the number
of female fish was observed with a corresponding drop in the male
fish after ATR exposure when compared to the control tank with
DMSO (Fig 2A). While we consistently noted a small number of
ambiguous-looking fish by external inspection at 3.5, 4 and 6
months of ATR treatment, histological gonadal analysis after six
months of treatment confirmed the correct sex assignment for all
fish (Fig 2B). Despite previous reports that ATR or estrogen
exposure in either a laboratory or field setting resulted in
feminized male frogs with testicular oogenesis [10], we found no
obvious ovi-testes phenotype in ATR exposed fish. This difference
may reflect the length of ATR exposure or the older age of fish
examined in our study. Similar to our findings, chronic exposure
to estrogens also led to an increase in the ratio of female fish, but
showed no intersex fish [26]. At this time we are unable to
eliminate the possibility that these effects reflect the actions of an
active ATR metabolite, although others showed previously that
ATR persists in similar aqueous conditions at doses of 5 mg/L
[16]. Nonetheless, our results show that exposure to environmen-
tally relevant but high doses of ATR dramatically increased
aromatase levels and increased the percentage of female fish.
ATR activates all NR5A receptors
To determine if ATR might directly affect NR5A receptor
activity, and thus account for the increased levels of endogenous
zcyp19a1 transcripts, cellular reporter assays were performed.
Using JEG3 human placental cells, which contain modest amounts
of SF-1, ATR treatment activated the aromatase promoter in a
dose-dependent manner (Fig 3A). Similar activation was observed
with other SF-1 reporters including those with isolated NR5A
binding sites (Fig S1A). However no activation was observed using
the parent reporter or with mutant SF-1 binding sites (Fig 3A and
S1B) showing that ATR effects depend on DNA binding and
receptor occupancy of the promoter, as suggested previously
[35,38]. Activation by ATR was enhanced greatly by overexpres-
sion of mSF-1 in JEG3 or HepG2 cells (Fig 3A and 5A), similar to
results obtained in human H295R adrenal cortical cells [38].
Figure 2. Chronic exposure to ATR increases the percentage of
female zebrafish. A. The percentage of female zebrafish is shown
after chronic exposure to DMSO and increasing ATR concentrations
(mM). The number of female fish was assessed visually at three, four
(data not shown) and at six months, as shown. Visual inspection for sex-
specific landmarks (body shape, body color, fin shape) at both stages
suggested an increase in the ratio of female to male fish. Following
visual inspection of six month old fish, unambiguous assignment of sex
was determined by morphological inspection of gonads. ATR treatment
began at 17dpf post-hatching. B. Representative pictures of fish treated
with ATR and corresponding gonadal sections stained with hematoxylin
and eosin. Oocytes within the perinuclear follicles of the ovary are
indicated (black arrowhead), and spermatozoa in the testis are indicated
(white arrowhead).
doi:10.1371/journal.pone.0002117.g002
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selective for SF-1 [35], we find that in all responsive cell lines ATR
can also activate hLRH-1 (NR5A2) and its close zebrafish ortholog
ff1d, which is expressed in embryonic male gonads [24](Fig 3A).
Moreover, knocking-down hLRH-1 in human HepG2 liver cells
greatly attenuated ATR activation of the aromatase reporter
demonstrating a dependence on this NR5A receptor (Fig S5).
Based on these findings, we suggest that all NR5A subfamily
receptors will be responsive to ATR.
In contrast to the activation of the mammalian and fish aromatase
reporter, ATR failed to activate an ERE-reporter in the presence of
hERa and estradiol (Fig 3B), consistent with ATR inability to
activate the estrogen responsive zcyp19a2 in vivo (this study and
[31]). Furthermore, no significant activation of NR5A was observed
with other estrogenic compounds, although a reproducible but
modestincreaseinreporteractivitywasnotedwithgenistein(Fig3C).
Thus, out of the major classes of EDCs, NR5A receptors appear to
be selectively and highly responsive to ATR.
Further studies aimed at discerning the cellular mechanisms of
ATR revealed that inhibitors of both the MAPK and PI3K
decreased or eliminated activation by ATR, whereas disrupting Gi,
some Gq (PTX), as well as PLC signaling did not block the effects of
ATR (Fig 4A). These results were consistent with ATR’s rapid
activation of the MAPK pathway, followed by peak phosphorylation
of SF-1, and activation of the PI3K pathway as determined by
phosphorylation of Akt/PKB (Fig 4B). Furthermore, because others
have suggested that ATR inhibits phosphodiesterases and elevates
cAMP [9,39], we asked if ATR directly increased cellular levels of
cAMP in JEG3 responsive cells. At activating ATR concentrations
(1 mM) we observed a significant and consistent increase in cellular
cAMP, albeitat levels muchlowerthan thoseobtained with forskolin
(Fig 4C). Despite these lower levels of cAMP stimulation, forskolin
(10 mM), as wellas EGF (50 mg/L), activate the aromatase promoter
to similar levels observed for ATR (Fig S2). We also asked if ATR
might bind directly to SF-1 to either increase DNA binding or act as
a ligand. However, ATR neither enhanced nor repressed DNA
Figure 3. ATR activates NR5A receptors, but does not activate ERa.A .Luciferase activity is shown after transfection of human placental JEG3
cells with ARO-Luc reporter (200 ng) and the parent reporter (pGL3-Luc) with mSF-1, hLRH-1 or zff1d expression vectors (25 ng). Drug treatments
with EDCs at the dose indicated was for 24 hrs. B. JEG3 were transfected with the ERE-Luc (50 ng) and hERa (5 ng) and treated with 17bE2 (0.1 mM)
with or without ATR (0.1–10 mM). Cells were treated with drug for 24 hr. C. Luciferase activities in JEG3 cells following treatment with EDCs,
concentrations are indicated (ranging from 1 nM to 10 mM). All cells were transfected with mSF-1 and Aro-Luc with concentrations as described for
panel A. T-test analysis reveal statistical significance with **p,0.01, *p,0.05.
doi:10.1371/journal.pone.0002117.g003
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also failed to significantly activate a Gal4-SF-1 ligand binding
domain (LBD) fusion constructs at high doses (Fig S3A). Finally,
ATR was unable to exchange for, or displace the bound bacterial
phospholipid ligand present in the LBD (H.A.I, unpublished data).
Collectively, these results suggest that ATR may not directly interact
with NR5A receptors, but instead activates three signaling pathways
knowntoactivateNR5Areceptors,includingphosphorylationofSF-
1, generation of SF-1 ligands, and increased production of cAMP.
All of these effects would be predicted to activate SF-1 further
[40,41,42,43].
ATR increases a cluster of genes involved in endocrine
signaling in specific cell types
ATR stimulation of reporter activity (Fig 5A) or induction of
endogenous hCyp19A (Fig 5B) were cell-specific with responsive
cell lines largely restricted to endocrine-like cells, including adrenal
cell lines Y1 and H295R, the human liver cell line HepG2, and
primary endometriotic H38 cells; these latter two cell lines express
moderate to high levels of SF-1 or LRH-1 [44,45]. Non-responsive
cell lines such as Ishikawa and HEK293 failed to show an ATR
response even after overexpression of SF-1 or LRH-1 (Fig 5A, data
not shown). The induction of endogenous Cyp19A1 in specific cell
lines is consistent with a previous report showing that 10 mM ATR
induced aromatase expression and activity in JEG3 and H295R
cells, but not in the breast cancer cell line MCF7 [46].
Interestingly, pluripotent cells such as P19 and mouse E14
embryonic stem cells were not responsive to ATR (Fig 5B) despite
expression of either SF-1 or LRH-1 (H.A.I. unpublished result);
again demonstrating that the ATR response is not restored by the
simple addition of exogenous NR5A receptors.
Having surveyed cell lines for their ATR responsiveness, gene
profiling was carried out with a human microarray (HEEBO chip)
to determine which transcripts in human JEG3 cells are most
responsive to ATR (Fig 5C). ATR-responsive genes were
determined with or without overexpression of SF-1. Remarkably,
a cluster of genes involved in hormone signaling was found to be
greatly upregulated following ATR treatment (24hrs, 10 mM).
Two of these are rate-limiting for steroid biosynthesis and include
steroidogenic acute regulatory protein (StAR) and P450 side-chain
cleavage (Cyp11A1), while other responsive genes include known
reproductive peptide hormones (INHa, LRH, GSUa, hCGß).
Among the top genes, several are known to be SF-1 targets and
inspection of other highly induced genes on our list revealed the
presence of NR5A binding sites in their promoter regions (FSTL3,
c15orf48, Insl4). Further analyses of these top genes showed that
their dose-dependent response to ATR treatment (Fig 5D) closely
matched the rank order found in the microarray analysis, with
FSTL3 and c15orf48 showing the highest response to ATR. Other
clusters of ATR-responsive genes relate to metabolism and growth
control (Table S1). Levels of SF-1 or LRH-1 transcripts were
unchanged by ATR (Fig 5D and data not shown).
The response to overexpressing SF-1 varied among these
endocrine ATR-responsive genes. Some ATR targets increased
further after adding SF-1, while others were either slightly repressed
or not affected by additional SF-1 (Fig 6A and Fig S4). For known
SF-1 downstream targets, such as Cyp19A1, the stimulatory effects
of ATR were diminished after knocking-down SF-1 by siRNA
Figure 4. ATR activates the MAPK, PI3K and modestly
stimulates cAMP production. A. Pharmacological inhibitors of
MAPK (U0126), PI3K (LY294002) or Gi (PTX), and PLC (U73122) signaling
were added, with ATR (10 mM) or without (DMSO), and with mSF-1
(25 ng), as indicated (+). All inhibitors were added 60 min prior to ATR
treatment. B. Western blotting was performed using antibodies against
phospho-ERK1/2, total ERK, phospho-SF-1, Flag, phospho-AKT and total
AKT using JEG3 cellular extracts transfected with Flag-tagged mSF-1
(1 mg). Twenty-four hours after transfection, cells were starved for 3 hrs
and treated with 10 mM of ATR for the indicated times (5 min to 24 hrs).
C. Levels of total cellular cAMP (pmol/ml) were determined in lysed
JEG3 cellular extracts according to Materials and Methods. Cells were
treated for 30 min with increasing concentrations of drug (estradiol,
ATR, or forskolin) as indicated (10 nM to 10 mM) following serum
starvation for 24 hrs as described in Materials and Methods. T-test
analysis reveal statistical significance with **p,0.01, *p,0.05.
doi:10.1371/journal.pone.0002117.g004
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PLoS ONE | www.plosone.org 5 May 2008 | Volume 3 | Issue 5 | e2117Figure 5. ATR is cell-specific and induces a cluster of genes involved in hormonal responses. A. Relative luciferase activities for the ARO-Luc
reporter are shown in responsive (HepG2, human liver) and non-responsive (Ishikawa, uterus, HEK293, embryonic kidney) cell lines following transfection
of mSF-1 (25 ng) with increasing doses of ATR. B. Relative levels of endogenous Cyp19A1are shown for different cell lines after ATR treatment (10 mM,24
hrs). Cell lines that showed a statistically significant increase in Cyp19A1 expression when compared to DMSO treatment indicated. C. List of endocrine/
reproductiverelated genes withtheir relative rankorderas definedbytheir fold enrichment followingATR treatment. KnownSF-1targetgenes andthose
that are cAMP responsive are indicated as (+). D. Relative expression levels of transcripts in JEG3 cells (without transfection of SF-1) are shown after DMSO
(-) or treatment with ATR (1 to 10 mM). JEG3 cells were treated with the indicated doses of ATR for 24 hrs and RT-qPCR analysis was carried out using
validated primers as indicated in Table S2. T-test analysis reveal statistical significance with **p,0.01, *p,0.05.
doi:10.1371/journal.pone.0002117.g005
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cells after siRNA knock-down of LRH-1 (Fig S5). Other genes
continued toshowa significant responseto ATR withthe caveatthat
levels of SF-1 persisted at 20% compared to control treated cells.
Nearly all ATR-induced genes identified here are known to be
sensitive to cAMP signaling (Fig 5C); the top three responsive
genes remain uncharacterized. Surprisingly, one of these ATR
targets is the serum glucocorticoid regulated kinase 1 (SGK-1).
This tyrosine intracellular kinase has historically been character-
ized as a glucocorticoid induced gene and regulates sodium
channels in the kidney. However SGK-1 is also expressed in
endocrine tissues and is thought to mediate FSH peptide hormone
signaling in the ovary [47,48,49]. Moreover, SGK-1 itself, is
upregulated by cAMP. Using siRNA to SGK, we found that
reducing cellular SGK-1 also attenuated (HSD11B) or eliminated
(Cyp19A1, Cyp11A1, LHß) further enhancement by ATR
(Fig 6B). These unexpected results suggest that the intracellular
kinase SGK-1, in addition to NR5A receptors, might participate in
ATR signaling.
Discussion
Our in vivo and in vitro analyses of ATR strongly suggest that
this widely used herbicide affects hormone signaling and endocrine
Figure 6. Overexpression of SF-1 enhances ATR effects, while knock-down of SF-1 and SGK-1 diminish or attenuate ATR effects on
selective genes. A. Relative endogenous transcript levels in JEG3 cells are shown with and without mSF-1 and with or without ATR treatment (24
hrs, 10 mM). B. Relative expression of transcripts in human JEG3 cells after transfection with si-RNAs directed to human SF-1 (si-SF-1, 50 nM) and
human SGK-1 (si-Sgk1, 30 nM) in JEG3 cells, with DMSO (black bars) or with ATR treatment (gray bars, as described above). The fold induction with
ATR treatment is indicated above bars. Levels of endogenous human SF-1 and human SGK-1 are shown after si-RNA treatment.
doi:10.1371/journal.pone.0002117.g006
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we found that acute and chronic exposure to ATR significantly
increased the endogenous levels of zcyp19a1 encoding gonadal
aromatase and altered the normal sex ratio in environmental
conditions in a relevant vertebrate model system. Moreover, our
cellular data illustrate that ATR induces a cluster of endocrine-
related genes, including Cyp19A1. Endocrine-related cell types
with a capacity for steroidogenesis appear to be especially sensitive
to ATR, as demonstrated by the exquisite cellular specificity of the
ATR response. Finally, based on the fact that many of these ATR
responsive endocrine targets are downstream of both SF-1 and
cAMP signaling, we propose that the selective effects of ATR in
endocrine cell types are mediated by convergent regulation of
NR5A receptors and elevated cAMP.
Strong field and laboratory evidence show that low levels of
atrazine (0.1–3 ppb or mg/L) result in gonadal abnormalities [11]
and increase parasitic infections [50,51,52]. In contrast to
unexposed wilderness areas where no detectable ATR can be
found, ATR and its active metabolites easily reach concentrations
of 6–12 ppb [11,53] in shallow ground water near agricultural
fields with some heavily exposed agricultural lands cited to reach
just under 500 ppb [50]. While the precise environmental levels of
ATR can vary greatly, the doses used in our zebrafish study (0.01
to 0.1 mM or 2.1 to 22 ppb) fall within lower levels of ATR
contamination, with our lowest dose just under the acceptable
amounts of 3 ppb allowed in human drinking water (http://www.
epa.gov/safewater/dwh/c-soc/atrazine.html). Based on our data,
we would predict that relatively low doses of ATR might adversely
influence normal hormone signaling in young fish.
The precise mechanism of action of ATR remains controversial.
Consistent with the fact that ATR does not directly interface with
classic estrogen signaling [9], ATR had no effect on the estrogen
responsive zcyp19a2 or an ERE-Luc reporter. While ATR is
suggested to inhibit phosphodiesterase and increases cellular pools
of cAMP; others have suggested that PKA signaling is not essential
for stimulation of aromatase in H295 cells [35]. However, in JEG3
cells, we do find that ATR easily activates a CRE-LUC reporter
(Fig S2B), and can elevate cellular cAMP, albeit at much lower
levels than observed for forskolin. Interestingly, these same
equivalent concentrations of ATR (10 mM) elicit a prominent
effect on aromatase reporter activation, similar to activation
observed by either EGF (50 ng/l) or forskolin (1 mM, Fig S2A).
Interestingly, we also find that ATR induces the cAMP-
phosphodiesterase (PDE) 4D, which is expressed in human fetal
tissues [54] and is proposed to mediate inflammatory responses in
the myometrium [55]. Our findings are consistent with the known
regulation of PDE4D expression by cAMP [55], and suggest that
prolonged ATR stimulation partially dampens cAMP signaling;
thus the degree of PDE4D might account for low cAMP levels
observed after 24 hr treatment with ATR (Fig 4C), and the noted
absence of cAMP in other ATR-treated cell lines [35].
The recent suggestion that ATR binds directly to SF-1 [38]
would easily account for ATR’s cell selectivity that we and others
have observed [46]. While such a straightforward mechanism is
attractive, our data would argue that the mechanism of ATR is
much more complex. Indeed, several lines of evidence suggest that
ATR might not function by directly binding to NR5A receptors, at
least in the cellular and biochemical assays used in this study. First,
introducing or increasing levels of NR5A receptors failed to
recapitulate an ATR response in non-responsive cell lines. Second,
ATR failed to activate a Gal4-LBD SF-1 fusion or increase DNA
binding of SF-1. Third, ATR failed to alter coactivator peptide
recruitment using an alpha screen assay (data not shown). Fourth,
ATR failed to displace the bacterial phosphatidyl glycerol or an
exchanged PIP3 ligand present in the SF-1 ligand binding pocket
(H.A.I, unpublished results). Finally, ATR stimulates SF-1 LBD
pocket mutants (data not shown), which have been designed to
occlude and prevent phospholipid binding in the large 1100 A ˚ 3
LBD cavity [56]. Taken together, alternative mechanisms must
account for this cell specific pharmacological response.
ATR also activates PI3K signaling as evidence by the increase
phosphorylation of AKT or protein kinase B. Moreover, inhibitors
of PI3K signaling block the ability of ATR to stimulate an SF-1
cellular reporter. Our findings broaden the actions of ATR to
other signaling pathways, and are consistent with the fact that SF-
1 is responsive to both PKA and PI3K signaling [42], as is the
stress induced kinase SGK-1 [57]. Interestingly, SGK-1 is found in
many steroidogenic endocrine tissues and is expressed highly in
cell lines found to be responsive to ATR, including Y1, JEG3,
H295R, H38 endometriotic cells, but not in HEK293 or Ishikawa
(data not shown). Although knock-downs of SF-1 [38] and SGK-1
attenuate the ATR response on some target genes, overexpression
of SGK-1 and/or SF-1 are insufficient to induce an ATR response
in non-responsive cell lines (Fig 5A and data not shown). These
data show that while SF-1 and SGK-1 participate in ATR actions,
a more comprehensive genome wide survey is needed to identify
the full spectrum of ATR targets in the entire endocrine system.
Our profiling of ATR-treated JEG3 cells now provides new
ATR-responsive genes for thoroughly studying the potential
environmental impact of ATR in wild life and in humans. For
example, SGK-1 is of interest given its noted upregulation in the
endometrium of women with unexplained infertility suggesting
that this kinase is important for implantation and maintenance of
early pregnancy [58]. Another gene implicated in human placental
health is the top ATR-induced gene, follistatin-like 3 (FSTL3).
Elevated FSTL3 transcripts in humans have been linked to
hypoxia [59] and intrauterine growth restriction [60], and in mice
overexpression of FSTL3 results in gonadal defects [61]. Taken
together these findings suggest that further research is needed to
determine whether high and/or chronic exposure to ATR in
humans compromise normal fertility and contribute to reproduc-
tive diseases.
In addition to known endocrine transcripts, it was surprising to
find that ATR also induced expression and weakly activated the
early response NR4A receptors (Nor1 and NGFI-B, Fig 5 and
S2C). It is worth noting that these nuclear receptors promote
gluconeogenesis in vivo, and are directly regulated by cAMP in
HepG2 liver cells [62]. Nor1 is also reported to directly regulate
SGK-1 [63]. In addition to glucose homeostasis, members of the
NR4A family are activated in macrophages as part of the
inflammatory response and are implicated in TCR-mediated cell
death and thymocyte-negative selection [64,65]. Thus, it is feasible
that activation of Nor1 and NGF-IB might account for other
physiological effects noted for ATR including decreased survivor-
ship in amphibians [52,66], and impaired immune responses in
rodents [67,68,69].
Although our in vivo analysis focused solely on Cyp19A1
expression and sex ratios in exposed zebrafish, the fact that ATR
upregulates several peptide hormones and steroidogenic genes in
mammalian cells suggests that the in vivo effects of these triazine
herbicides will be much broader, extending well beyond estrogen
metabolism. Further studies using model organisms, where
genomic approaches are feasible, should help to determine the
full extent of ATR effects on endocrine signaling and other
physiological responses, including the immune response and early
embryonic development [70]. Given the current pervasive use and
persistence of ATR in the environment, our findings support
environmental concerns that ATR poses a potential risk to the
ATR and the Endocrine Network
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suggest that further research is needed to determine how this non-
estrogenic EDC influences the mammalian embryonic and adult
endocrine system.
Materials and Methods
Biological Reagents
Antibodies, chemicals, oligonucleotides, plasmids and cell lines
used are specified in Text S1.
Plasmids
Full length mouse SF-1 (mSF-1) was PCR amplified from HA-
mSF-1/pCIneo. Full length human LRH-1 (hLRH-1, cloned from
human ductal carcinoma T47-D cDNA) was PCR amplified and
subcloned into 3x FLAG pcDNA3. Full length zebrafish nr5a ff1d
was isolated from zebrafish cDNA obtained from total body RNA
by PCR amplification, and subcloned into 3x FLAG pcDNA3.
Aromatase-Luc (ARO-Luc) was described previously [56]. ERa
and ERE-TATA-Luc vectors were generous gifts from Dr. S Kato
(University of Tokyo, Japan).
Cell Culture and Cell Lines
JEG3, HepG2 and H295R cells were maintained in DMEM/
H-21, 4.5g/L glucose supplemented with 10% fetal bovine serum
(FBS) and 1x penicillin/streptomycin (P/S). Y1 and human H-38
endometriotic cells were maintained in DMEM/F12 with 15%
Horse serum, 2.5% FBS and P/S, MA10 cells were maintained in
Waymouth’s with 15% horse serum and P/S, p19 cells were
maintained in aMEM with 10% FBS, E14 were maintained in
DME/H-21 with 15% fetal calf serum and P/S.
For transient transfections, cells were plated at a density of
20,000 cells/well in 24-well plates in phenol red-free DME H-21,
4.5 g/L glucose with 4% charcoal-dextran-stripped (CDS) FBS.
Cells were co-transfected with 200 ng ARO-Luc reporter plasmid
and 3x FLAG-mSF-1 expression vectors using FuGENE 6 (Roche,
Indianapolis, IN). Cells were treated with indicated drugs for 6 hr
before harvesting. Thereafter, luciferase activity was determined
using the Ventas Microplate Luminometer (Turner Biosystems,
Sunnyvale, CA). All transfections were performed in triplicate and
repeated at least three times.
Western blot analysis was carried out in JEG3 cells transfected
(24 hr) with 3x FLAG-mSF-1 and serum starved in phenol red-free
medium. Following serum starvation, cells were treated with drugs
for various times as indicated, washed with ice cold phosphate
buffered saline (PBS) and lysed with ice cold 20 mM Tris-HCl
pH 7.4, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1%
NaDeoxycholate, 1% Triton X-100, 0.1% SDS, Complete
Protease Inhibitor Cocktail (Roche), 1 mM phenylmethylsulpho-
nyl fluoride, 1x Phosphatase Inhibitor Cocktail I and II (Sigma-
Aldrich, St. Louis, MO). Protein concentration was determined
using Pierce Coomassie Protein Assay Kit (Pierce, Rockford, IL).
Twenty five micrograms of total protein was electrophoresed on
NuPAGE 4%–12% Bis-Tris gels (Invitrogen) and separated
proteins transferred and probed with antibodies against phos-
pho-Akt (Ser473) (1:1,000), Akt (1:1,000), phospho-p44/p42
(1:1,000), p44/p42 (1:1,000), pSF-1 (1:2,500) and Flag M2
(1:5000). Signal was detected using SuperSignal West Femto
Maximum Sensitivity Substrate (Pierce).
Levels of cellular cAMP were determined on whole cell extracts
prepared by the protocol provided with the R&D Systems ELISA
cAMP Parameter Assay Kit (Minneapolis, MN). All values were
normalized to internal standards with a standard curve ranging
from 0.78 to 200 pmol/mL, and were measured on a Thermo
Malti-Skan Ex plate reader at 450 nm. Two independent assays
were carried out with each experimental condition done in
triplicate.
Zebrafish and EDCs exposure
Adult zebrafish (Danio rerio) were maintained in recirculating
aquarium tank at 28 C on a 14h:10h light:dark cycle. Fertilized
eggs were harvested and juveniles were raised until 17 days post
fertilization (dpf). Fifteen zebrafish at 17dpf were exposed together
in the glass beaker containing 500 mL of aquarium water for 3
days with either DMSO vehicle (0.1%, v/v) as the control group
or with multiple classes of EDCs. Total RNAs from 5 fish were
pooled and purified using TRIzol (Invitrogen, CA). For assessing
ATR effects on the percentage of male and female zebrafish, 17dpf
zebrafish was exposed for 6 months to either DMSO, or 10
27 M,
10
26 M and 10
25 M ATR. ATR was diluted from a stock
solution and added to fish water; tanks were changed three times
per week with fresh ATR. All research involving zebrafish were
approved and carried out according to guidelines of the UCSF
IACUC committee.
For gonadal histology, fish were anesthetized with 100 mg/L
tricaine methanesulphonate (Sigma) and fixed with 95% of EtOH,
4% of formalin and 2% of glacial acetic acid, sectioned (4 mm),
and stained with H & E.
RNA Analysis
Total RNA from cultured cells was extracted using TRIzol. For
quantitative PCR (qPCR), cDNA was synthesized from 2 mgo f
total RNA with Superscript III Reverse Transcriptase (Invitrogen)
using random hexamer primers (Amersham Biosciences). RT-
qPCR was performed using the SYBR Green PCR Master Mix kit
(Applied Biosystems, Foster City, CA) with gene-specific primer
pairs. All primer sets were designed by Primer Express v2.0;
Applied Biosystems and validated to ensure amplification of a
single product with appropriate efficiency. Data obtained from the
PCR reaction was analyzed using the comparative CT method
(User Bulletin No. 2, PerkinElmer Life Sciences). All primer
sequences are listed in Table S2.
Microarray Analysis
HEEBO (Human Exonic Evidence Based Open-source) arrays
were printed in-house at the Center for Advanced Technology
(UCSF, CA). Total RNAs from JEG3 cells were prepared using
RNeasy (Qiagen, Valencia, CA). For each array, total RNA
(12.5 mg) obtained for each sample was reverse transcribed and
labeled with amino-allyl dUTP using reverse transcriptase III and
Oligo-dT/random primer mixture (Invitrogen, Carlsbad, CA).
cDNA was purified using MinElute PCR Purification Kit (Qiagen,
CA). Two mg of cDNA was coupled to Cy3 or Cy5 dye
(Monofunctional NHS-ester Dye, Amersham, Piscataway, NJ).
Cy3/Cy5 labeled cDNAs were purified, combined, and hybridized
in a sealed chamber at 65 C for 48 hrs. Slides were washed in
Solution I (3x SSC, 0.2% SDS) at 55C 1 min, Solution II (1x SSC)
1min twice at room temperature (RT), Solution III (0.2x SSC)
1 min at RT and quickly dried by centrifugation. Hybridized
slides were scanned using Axon Slide Scanner 4000B and data
were analyzed by Genepix 6.0 software (Molecular Devices, CA).
Supporting Information
Text S1
Found at: doi:10.1371/journal.pone.0002117.s001 (0.02 MB
DOC)
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indicated abovebar graphs with or without SF-1and with increasing
concentrations of ATR added. B. Luciferase activity is shown with a
hypothalamic SF-1 target gene using a wild type and mutant
promoter. The SF-1 binding site is mutated in the mutant promoter
(mutant SF-1 RE). The promoter is ataxin 2 binding protein.
Found at: doi:10.1371/journal.pone.0002117.s002 (0.11 MB PDF)
Figure S2 A. Luciferase activity in JEG-3 cells following
treatment with ATR (10 mM), EGF (50 mg/L) or Forskolin
(10 mM) for 24 hrs. All cells were transfected with 25 ng of
mSF-1 and 200 ng of Aro-Luc reporter plasmid. B. Luciferase
activity for JEG-3 cells transfected with the pCRE-Luc (200 ng,
pCRE-Luc, Clontech) and with indicated amount of ATR added
for 24 hrs. C. JEG-3 cells were transfected with 5x OH-Luc
reporter (200 ng) and NGFIB (10 ng), treated with indicated
amount of ATR added for 24 hrs.
Found at: doi:10.1371/journal.pone.0002117.s003 (0.14 MB PDF)
Figure S3 A. GAL-4 fused luciferase activity is shown using
200 mg of GAL-4 reporter, pFR-Luc (Stratagene), as indicated
with 100 mg of mSF-1 (hinge-LBD aa105 to 462) or hLRH-1
(aa198 to 562), with increasing concentrations of ATR added. B.
EMSA assay. For EMSA binding assays, the mMIS SF-1 binding
site was used. Sequences are described in Text S1. The
concentration of ATR is indicated, and was added to binding
buffer and then incubated with purified mSF-1 containing the
entire DNA binding domain.
Found at: doi:10.1371/journal.pone.0002117.s004 (0.22 MB PDF)
Figure S4 A. Cluster analysis of significant (P,0.001) changes in
gene expression after ATR (10 mM, 24 hrs) compared to DMSO,
and with or without transfection of mouse SF-1 (SF-1+ or SF-1-).
The relative fold change is indicated on the bar legend to the left.
B. Relative expression levels in JEG3 cells (with/ without
transfection of mSF-1) after DMSO (-) or treatment with ATR
(10 mM). JEG3 cells were transfected with5 mgo fm S F - 1a n dt r e a t e d
with the ATR for 24hrs with RT-qPCR analysis carried out using
validated primers as indicated in Table S2. Endogenous expression
levels of hSF-1 are shown by RT-qPCR (right upper panel).
Found at: doi:10.1371/journal.pone.0002117.s005 (0.19 MB PDF)
Figure S5 HepG2 liver cells were transfected with 200 ng of
ARO-Luc and with either 100 ng siRNA of control (sicRNA) or
hLRH-1 (si-hLRH-1), left panel. Relative luciferase activities after
drug treatment are shown as mean values +/2s. d. Endogenous
transcript levels of hLRH-1 are shown as determined by RT-
qPCR, right panel.
Found at: doi:10.1371/journal.pone.0002117.s006 (0.09 MB PDF)
Table S1
Found at: doi:10.1371/journal.pone.0002117.s007 (0.05 MB PDF)
Table S2
Found at: doi:10.1371/journal.pone.0002117.s008 (0.06 MB
DOC)
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